Jump to content
Powered by
  • BIOPRO BW
  • Healthcare industry
  • Bioeconomy

Healthcare industry

Main navigation

  • Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close
  • Databases

    Databases

    Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Article - 17/08/2015 AG_Papatheodorou.jpg

    CDT – a bacterial toxin that mediates its own delivery into cells

    Clostridium difficile is totally harmless in healthy people. However, in combination with antibiotics it can cause severe diarrhoea and intestinal inflammation in elderly and debilitated people. But how does the spore-forming, rod-shaped bacterium deploy its power? And how does it enter the cell? Dr. Panagiotis Papatheodorou and his colleagues from the Institute of Experimental and Clinical Pharmacology and Toxicology (Director: Prof. Dr. Klaus…

    https://www.gesundheitsindustrie-bw.de/en/article/news/cdt-a-bacterial-toxin-that-mediates-its-own-delivery-into-cells
  • Article - 15/06/2015 Foto von Prof. Dr. Marja Timmermans in einem Maisfeld.

    Marja Timmermans: Humboldt Professor with a penchant for small RNAs

    Molecular biologist Marja Timmermans has found out how plant cells can communicate with each other using mobile ribonucleic acid molecules. The use of small RNAs (sRNA) is a fundamental principle that applies not only to plant cells, but also to animal and human cells. These days, Timmermans' laboratory methods are used around the world. She has recently been awarded Germany’s most highly endowed international research award - the Alexander…

    https://www.gesundheitsindustrie-bw.de/en/article/news/marja-timmermans-humboldt-professor-with-a-penchant-for-small-rnas
  • Article - 18/05/2015 The figures shows a model of a spherical parvovirus. Parvoviruses are non-enveloped viruses, which makes them rather resistant against external influences.

    Parvoviruses can destroy brain tumours

    Parvoviruses such as H-1PV have been shown to selectively attack and destroy human cancer cells. However, they are unable to replicate in healthy human cells. A preliminary clinical trial is currently being carried out to assess the suitability of parvoviruses for treating malignant brain cancer. Scientists from the German Cancer Research Center (DKFZ) have now discovered the cause of the selective effect of H-1PV. The finding helps identify…

    https://www.gesundheitsindustrie-bw.de/en/article/news/parvoviruses-can-destroy-brain-tumours
  • Article - 11/05/2015 Microscopic image of MTSS1 expression.

    Lung cancer: MTSS1 is a putative marker of tumour progression and metastatic disease

    Lung cancer is one of the most common malignant diseases and one of the leading causes of cancer-related deaths worldwide. 90% of all lung cancer cases in men and 80% in women are due to long-term exposure to tobacco smoke. In Germany, around 140 new cases are diagnosed every day, and 50,000 people die of lung cancer every year. PD Dr. Gian Kayser, senior consultant in the Department of Clinical Pathology at Freiburg University Medical Centre,…

    https://www.gesundheitsindustrie-bw.de/en/article/news/lung-cancer-mtss1-is-a-putative-marker-of-tumour-progression-and-metastatic-disease
  • Article - 30/03/2015 The photo shows Dr. Sommershof in the laboratory, using a flow cytometer.<br />

    How psychological stress weakens the immune system

    Too much stress makes you sick – this is the widely held opinion. But exactly how chronic psychological stress affects our body is not yet fully understood. This is the question Dr. Annette Sommershof and her team from the University of Konstanz are trying to answer. The scientists are exploring stress-related changes in the immune system and have found evidence for the observation that long-term stress weakens the immune system, resulting in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-psychological-stress-weakens-the-immune-system
  • Article - 16/03/2015 22977_de.jpg

    Heike Brötz-Oesterhelt - searching for novel antibiotics in bacteria

    Microbial metabolic products can be used in the fight against dangerous pathogens such as multidrug-resistant bacteria. Since summer 2014, microbiologist Prof. Dr. Heike Brötz-Oesterhelt has been investigating the mechanisms of action of bacterial substances at the University of Tübingen with the aim of paving the way for new antibiotics. Interesting candidates have already been identified.

    https://www.gesundheitsindustrie-bw.de/en/article/news/heike-broetz-oesterhelt-searching-for-novel-antibiotics-in-bacteria
  • Article - 16/02/2015 Model of the protein complex.

    The cellular power station of the cholera pathogen – from the structure to new antibiotics

    The bacterium Vibrio cholerae causes cholera, a severe disease that affects up to 3.5 million people a year. A team of scientists from the universities of Freiburg, Hohenheim and Konstanz have now gained new insights into the way the bacterium produces energy. They have elucidated the structure and function of the bacterium’s energy-production machinery. The research results provide new insights into biochemical energy production and the…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-cellular-power-station-of-the-cholera-pathogen-from-the-structure-to-new-antibiotics
  • Article - 26/01/2015 Photo showing a laboratory involved in the TTU "Malaria". The photo shows two scientists working at a work bench.

    Pooling efforts against infectious diseases in Germany

    Over 150 scientists at various locations throughout Germany work together as part of the German Centre for Infection Research (DZIF). The centre focuses on the development of new diagnostic, preventive and therapeutic methods for treating infectious diseases. Scientists from the University and University Hospital of Tübingen and the Max Planck Institute for Developmental Biology are also part of the project. The researchers from Tübingen are…

    https://www.gesundheitsindustrie-bw.de/en/article/news/pooling-efforts-against-infectious-diseases-in-germany
  • Article - 22/12/2014 Schematic showing T-cell activation without and without CTLA4.

    The immune system – both weak and overreactive in the absence of CTLA4

    The ability to recognise a pathogen and combat it effectively is certainly one of the most complex and sophisticated processes the human body has evolved. People with an immunodeficiency or autoimmune disease may have a genetic defect in one of the genes involved in the immune response. Working with immunologists from London scientists Desire Schubert and Prof. Dr. Bodo Grimbacher from the Centre for Chronic Immunodeficiency CCI at the Freiburg…

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-immune-system-both-weak-and-overreactive-in-the-absence-of-ctla4
  • Article - 24/11/2014 Three-dimensional microscopic representation of a synthetic vesicle that is invaded by bacteria.

    Lipid zipper triggers bacterial invasion

    Millions of people die each year from infections both in developing and industrial countries. There is still no effective treatment for a large number of diseases caused by pathogens. In order to treat infectious diseases effectively, we need to understand the mechanisms that bacteria use to infect human cells. The cytoskeleton of the host cell usually plays a key role in this process. Researchers at the University of Freiburg have discovered a…

    https://www.gesundheitsindustrie-bw.de/en/article/news/lipid-zipper-triggers-bacterial-invasion
  • Article - 20/10/2014 The photo shows three QIAGEN Lake Constance staff in the laboratory with a mobile diagnostics device.<br /> <br />

    QIAGEN Lake Constance – pocket-sized laboratories for the efficient identification of pathogens

    Quick, simple and decentralized – this is how QIAGEN Lake Constance GmbH envisages diagnostics applications in the future. The Stockach-based QIAGEN subsidiary develops test systems for point-of-need diagnostics, i.e. tests that can be carried out in close proximity to the sample collection point, for example in GP surgeries. They enable the rapid identification of pathogens, and as a result the timely initiation of suitable treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/news/qiagen-lake-constance-pocket-sized-laboratories-for-the-efficient-identification-of-pathogens
  • Article - 29/09/2014 The photo shows a multi-well plate used for the automated and parallel analysis of many samples.

    myPOLS Biotec UG - made-to-measure enzymes for diagnostics and research

    The company myPOLS Biotec UG, a spin-off from the University of Konstanz, specializes in services involving DNA and RNA polymerases and creates artificial enzymes by evolution in test tubes. These next-generation polymerases can be used for many research and diagnostics applications. myPOLS Biotec’s polymerases are promising enzymes for future applications with the potential to make the detection of pathogens and DNA analysis faster and easier.

    https://www.gesundheitsindustrie-bw.de/en/article/news/mypols-biotec-ug-made-to-measure-enzymes-for-diagnostics-and-research
  • Article - 11/08/2014 Photo showing a real-time PCR system in the laboratory.

    dsl-Labor: developing PCR tests for medical diagnostics

    PCR has become a common application in medical diagnostics, in areas ranging from the detection of microbes to genetic testing. The demand for new tests is huge, given that there is a seemingly endless list of applications for which PCR can be used. dsl-Labor für Molekulargenetische Diagnostik specialises in the development of PCR tests and also gives advice and training to medical laboratory personnel. Veterinarians are among the company’s major…

    https://www.gesundheitsindustrie-bw.de/en/article/news/dsl-labor-developing-pcr-tests-for-medical-diagnostics
  • Dossier - 16/06/2014 The photo shows food scientists evaluating different cheeses.

    Biotechnology as a tool for the production of food

    Biotechnology opens up numerous opportunities for the food industry. The targeted use of biotechnological methods can, amongst other things, help reduce the quantity and number of unhealthy ingredients in foods as well as degrade allergenic substances. Genomic research and targeted breeding also greatly facilitate progress in agriculture. Food biotechnology therefore contributes significantly to saving resources, optimising harvest yields and…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/biotechnology-as-a-tool-for-the-production-of-food
  • Article - 02/06/2014 The photo shows the Konstanz researchers Dieter Spiteller, Michael Weiss, Ann-Katrin Felux, Alasdair Cook, Thomas Huhn, Karin Denger and David Schleheck in a laboratory.

    Researchers shed light on important metabolic pathway

    A research team led by microbiologist Dr. David Schleheck, in cooperation with chemists from the University of Konstanz, has discovered how sulpho-glucose is degraded in Escherichia coli bacteria. As this sulphurous glucose analogue is produced by all photosynthetically active organisms, the researchers’ discovery is of great importance for our understanding of the global sulphur cycle.

    https://www.gesundheitsindustrie-bw.de/en/article/news/researchers-shed-light-on-important-metabolic-pathway
  • Dossier - 02/06/2014 13521_de.jpg

    Bioanalysis – techniques for the characterization of biological material

    Science constantly provides researchers with new challenges biologists and bioanalysts have to deal with and which come from sources as varied as the ever increasing number of resistant pathogenic bacterial strains or the famine conditions in Third-World countries. In the search for scientific truths bioanalysis is the development optimization and application of the entire range of analytical methods available. However we need to keep in mind…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/bioanalysis-techniques-for-the-characterization-of-biological-material
  • Article - 12/05/2014 21187_de.jpg

    A DNA cracker from Ulm for making clean drinking water

    Drinking water that is pathogen-free and safe for humans flows from German taps. There is no nutrient as vital to human beings as water and – at least in Germany – that is subjected to so many checks and controls. Nevertheless, access to clean drinking water is not to be taken as given. According to the latest WHO figures (2011), 768 million people do not have access to healthy drinking water, especially in some of the poorer African countries.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/a-dna-cracker-from-ulm-for-making-clean-drinking-water
  • Article - 28/04/2014 Co-existence mechanism of gram-positive staphylococci and gram-negative bacteria Gram-negative bacteria. (S. marcescens, P. aeruginosa, V. harveyi und C. subtsugae). The staphylococci secrete two compounds (Yayurea A and B) that inhibit the growth and chemical communication of gram-negative bacteria. Yayurea A and B are represented by their structural formula. The gram-negative bacteria are no longer able to produce compounds such as prodigiosin, pyocyanin, bioluminescence compounds and violacein.<br /> <br />

    New ways to interfere with bacterial strategies

    Bacteria themselves provide the key to their destruction. New insights into the growth and interaction between different pathogens are used in microbial genetics to develop new methods and active substances for combatting multidrug-resistant bacterial strains.

    https://www.gesundheitsindustrie-bw.de/en/article/news/new-ways-to-interfere-with-bacterial-strategies
  • Article - 22/04/2014 False-colour representation clearly reveals the presence of a biofilm consisting of a substance matrix (yellow) produced by Staphylococcus aureus bacteria (grey).

    Sugar code and hygiene in the fight against multi-resistant pathogens

    Horizontal gene transfer between bacteria is a major reason for the spread of bacterial antibiotic resistance. It is the transfer of bacterial DNA from one bacterium to another, even distantly related species, by bacteriophages, viruses that infect bacteria. Microbiologists from the University of Tübingen are investigating these mechanisms with the aim of finding new strategies that would effectively combat bacteria such as methicillin-resistant…

    https://www.gesundheitsindustrie-bw.de/en/article/news/sugar-code-and-hygiene-in-the-fight-against-multi-resistant-pathogens
  • Article - 31/03/2014 21168_de.jpg

    The growing significance of peptide therapeutics

    The therapeutic use of peptides lags behind that of proteins. And there are good reasons for this. However, it seems that this is beginning to change and that peptide therapeutics are growing in significance. As a matter of fact, peptides have become rather popular candidates for drugs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/the-growing-significance-of-peptide-therapeutics
  • Article - 10/03/2014 21148_de.jpg

    P450-catalysed glycopeptide biosynthesis

    Specific cytochrome P450 enzymes are essential for the biosynthesis of glycopeptide antibiotics such as vancomycin that are used as a last resort for the treatment of life-threatening bacterial infections. However, an increasing number of bacteria are developing resistances to these antibiotics as well. Researchers from the Max Planck Institute in Heidelberg are investigating the structure and function of these enzyme-antibiotics complexes in…

    https://www.gesundheitsindustrie-bw.de/en/article/news/p450-catalysed-glycopeptide-biosynthesis
  • Article - 17/02/2014 21025_de.jpg

    Soil bacteria explored as source of new antibiotics

    Two scientists from the Interfaculty Institute of Microbiology and Infection Medicine IMIT at the University of Tübingen PD Dr. Evi Stegmann and Dr. Yvonne Mast are exploring the biosynthesis of antibiotic substances with the aim of modifying them to make them suitable for application in the fight against multidrug-resistant bacteria.

    https://www.gesundheitsindustrie-bw.de/en/article/news/soil-bacteria-explored-as-source-of-new-antibiotics
  • Dossier - 10/02/2014 Electron microscope image of Staphylococcus aureus bacteria which have become resistant to many antibiotics.

    Multiresistant pathogens – a self-inflicted threat?

    Most bacterial infections have lost their capacity to cause terror thanks to antibiotics. However, the increase in antibiotic resistances is making the fight against bacterial pathogens rather difficult, and the widespread overuse and inappropriate use of antibiotics continues to fuel the increase in antibiotic-resistant bacteria. Strict surveillance strategies and hygiene rules have been in place for some years with the aim of ensuring the…

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/multiresistant-pathogens-a-self-inflicted-threat
  • Article - 25/01/2014 20891_de.jpg

    Call for responsible antibiotics prescription

    Heidelberg University Hospital and the University Medical Centre in Mannheim are working hard to counteract the increase of antibiotic resistance. Strategies include a European-wide system for infection surveillance, the training of health professionals in the responsible use of antibiotics and the search for novel antibiotic substances in unconventional organisms.

    https://www.gesundheitsindustrie-bw.de/en/article/news/call-for-responsible-antibiotics-prescription
  • Article - 20/01/2014 The photo shows a small metal device with wires and standing in a mount.

    Microarray copier – for copying DNA, RNA and protein arrays

    Dr. Günter Roth from the Centre for Biological Systems Analysis at the University of Freiburg is working on the development of a microarray copier that can almost at the push of a button copy arrays of any type of molecule DNA RNA and proteins from next-generation sequencing chips onto standard slides thereby combining the world of microarrays with the sequencing world. The approach has a huge application potential for the production of…

    https://www.gesundheitsindustrie-bw.de/en/article/news/microarray-copier-for-copying-dna-rna-and-protein-arrays

Page 4 / 10

sb_search.block.search_result.other.pages

  • eine Seite vor
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 10
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • Telemedicine BW
    • MDR & IVDR
  • Portals
    • BIOPRO BW
    • Healthcare industry
    • Bioeconomy
  • To top

stay informed

Subscribe to newsletter

Social Media

  • Xing
  • Twitter
  • LinkedIn
  • Rss
  • Privacy statement
  • Legal notice
  • Sitemap
  • Contact
© 2022
Website address: https://www.gesundheitsindustrie-bw.de/en/search